Re: Let us know the payment status—–Attaching the invoices

Home / QMedin / Re: Let us know the payment status—–Attaching the invoices

Dear Andrew/ Michael

As requested by you, We had sent the copy of the invoices 202002082 and
202002083 again on 25th March 2020.
Kindly update us regarding the payment status for the following
invoices.

Invoice Number Invoice date Invoice amount Articles requested by
202002082 06-Feb-20 GBP-72 Jesse Simpson
202002083 06-Feb-20 GBP-288 Rahul Dobariya
202002084 18-Feb-20 GBP-408 Rahul Dobariya

After the payment is initiated, request you to share the swift copy for
the remittance.

Thanks & Regards
Jayanthi Raghunath
QMed Services Pvt.Ltd
A-3, Shubham Centre, Cardinal Gracious Road,
Chakala, Andheri (E), Mumbai 400099, India.
Ph: 022-40054474/75
Email: articles@qmedin.com

On 2020-03-25 13:57, jayanthi@qmedin.com wrote:
> Dear Michael
>
> As per your mail below, please find attached herewith the scanned copy
> of the invoices 202002082 and 202002083.
> Once the payment is done,request you to share the swift copy for the
> remittances and the
> remittance details.
>
> Thanks & Regards
> Jayanthi Raghunath
> QMed Services Pvt.Ltd
> A-3, Shubham Centre, Cardinal Gracious Road,
> Chakala, Andheri (E), Mumbai 400099, India.
> Ph: 022-40054474/75
> Email: articles@qmedin.com
>>
>
> On 2020-03-24 20:25, Purchase Ledger wrote:
>> Good afternoon,
>>
>> Sincere apologies for the delay.
>>
>> For some reason, we do not have invoices 202002082 and 202002083 on
>> our system.
>>
>> Could you please send us copies so we can process all three invoices
>> for payment as soon as possible.
>>
>> Thanks,
>>
>> Michael
>>
>> FROM: QMed Services Pvt Ltd-Articles
>> SENT: 19 March 2020 08:33
>> TO: Andrew Harbrow ; Clinigen
>> Medical Information ; Purchase Ledger
>>
>> CC: ‘QMed Services Pvt Ltd-Articles’ ; ‘Vasumathi
>> Sriganesh’
>> SUBJECT: RE: Attaching the Invoice # 202002084 for the articles sent–
>> Sending article-S.N- 2, 17: Aldesleukin IL-2 Article request
>> IMPORTANCE: High
>>
>> Dear Andrew/ Michael
>>
>> Kindly update us regarding the payment status for the following
>> invoices.
>>
>> We would appreciate if you could help expedite the payment for all the
>> below mentioned invoices at the earliest. Once the payment is done,
>> request you to share the swift copy for the remittances and the
>> remittance details.
>>
>> INVOICE NUMBER
>>
>> INVOICE DATE
>>
>> INVOICE AMOUNT
>>
>> ARTICLES REQUESTED BY
>>
>> 202002082
>>
>> 06-Feb-20
>>
>> GBP-72
>>
>> Jesse Simpson
>>
>> 202002083
>>
>> 06-Feb-20
>>
>> GBP-288
>>
>> Rahul Dobariya
>>
>> 202002084
>>
>> 18-Feb-20
>>
>> GBP-408
>>
>> Rahul Dobariya
>>
>> Thanks & Regards
>>
>> Jayanthi Raghunath
>> QMed Services Pvt.Ltd
>> A-3, Shubham Centre, Cardinal Gracious Road,
>> Chakala, Andheri (E), Mumbai 400099, India.
>> Ph: 022-40054474/75
>> Email: articles@qmedin.com
>>
>> FROM: Andrew Harbrow [mailto:andrew.harbrow@clinigengroup.com]
>> SENT: 18 February 2020 14:04
>> TO: QMed Services Pvt Ltd-Articles
>> CC: Clinigen Medical Information
>> SUBJECT: RE: Attaching the Invoice # 202002084 for the articles sent–
>> Sending article-S.N- 2, 17: Aldesleukin IL-2 Article request
>>
>> Dear Jayanthi
>>
>> I confirm receipt. Invoice has been forwarded to Purchase Ledger.
>>
>> Kind regards
>>
>> Andy
>>
>> ANDREW HARBROW
>>
>> Head of Medical Information
>>
>> CLINIGEN GROUP
>>
>> t. +44 1932 824188 m. +44 7775 113598
>> e. andrew.harbrow@clinigengroup.com
>> w. http://www.clinigengroup.com [1]
>>
>> [2]
>>
>> [3]
>>
>> [4]
>>
>> [5]
>>
>> CELEBRATING EXCELLENCE IN HOSPITAL PHARMACY
>>
>> Open for nominations until 14TH FEBRUARY, 2020.
>> Enter online today: http://www.loveyourpharmacist.com [5]
>>
>> This email (including any attachments) is confidential to the intended
>> addressee and may be subject to copyright. If you are not the intended
>> addressee, please do not read, print, re-transmit, copy, store, alter
>> or otherwise disclose it or any of its attachments to anyone; nor
>> should you act in reliance on it or any of its attachments. Instead,
>> please notify the error to the sender by email and immediately
>> permanently delete this email and any of its attachments from your
>> system.
>> Emails sent to and from Clinigen Group plc and/or its subsidiaries may
>> be monitored and read for legitimate business purposes, notably to
>> ensure compliance with the law and our regulatory obligations. Emails
>> and their attachments cannot be guaranteed to be secure or error-free,
>> and you should protect your systems. Clinigen Group plc and its
>> subsidiaries do not accept any liability arising from interception,
>> corruption, loss or destruction of this email (including any
>> attachment) or if it arrives late or incomplete or with viruses.
>> Clinigen Group plc is a public limited company (registered in England
>> and Wales No.06771928) whose registered office is at Pitcairn House,
>> Crown Square, Centrum 100, Burton-on-Trent, Staffordshire, DE14 2WW.
>> Subsidiary trading companies are as follows: Clinigen Healthcare
>> Limited (registered in England and Wales No.06252720); Clinigen CTS
>> Limited (registered in England and Wales No. 05016103), both with the
>> same registered office as Clinigen Group plc; and Idis Limited
>> (registered in England and Wales No.02143039) whose registered office
>> is at Idis House, Churchfield Road, Weybridge, Surrey KT13 8DB.
>> Clinigen Specialty Pharmaceuticals (SP), Clinigen Clinical Trial
>> Services (CTS), Idis Managed Access (MA) and Idis Global Access (GA)
>> are all trading names of Clinigen Group plc and/or its subsidiaries.
>> For further information please consult our website
>> http://www.clinigengroup.com. [6]
>>
>> FROM: QMed Services Pvt Ltd-Articles
>> SENT: 18 February 2020 08:29
>> TO: Clinigen Medical Information ; Andrew
>> Harbrow
>> SUBJECT: Attaching the Invoice # 202002084 for the articles sent–
>> Sending article-S.N- 2, 17: Aldesleukin IL-2 Article request
>> IMPORTANCE: High
>>
>> Dear Rahul,
>>
>> Please find attached herewith the Invoice for the articles sent to you
>> on 13th and 14th of February 2020.
>>
>> Kindly arrange to make the payment within a month of the date of the
>> Invoice.
>>
>> Thanks & Regards
>>
>> Jayanthi Raghunath
>> QMed Services Pvt.Ltd
>> A-3, Shubham Centre, Cardinal Gracious Road,
>> Chakala, Andheri (E), Mumbai 400099, India.
>> Ph: 022-40054474/75
>> Email: articles@qmedin.com
>>
>> FROM: QMed Services Pvt Ltd(Articles) [mailto:articles@qmedin.com]
>> SENT: 14 February 2020 10:52
>> TO: ‘Clinigen Medical Information’
>> CC: articles@qmedin.com
>> SUBJECT: Sending article-S.N- 2, 17: Aldesleukin IL-2 Article request
>>
>> Dear Rahul,
>>
>> Sending you the following article/s by another mail/separate mails:
>>
>> S NO
>>
>> CITATION
>>
>> TITLE
>>
>> 2
>>
>> JAAPA. 2012 Jul;25(7):53-4.
>>
>> Amyotrophic lateral sclerosis.
>>
>> 17
>>
>> Semin Oncol. 1993 Dec;20(6 Suppl 9):3-10.
>>
>> Low-dose recombinant interleukin-2 therapy: rationale and potential
>> clinical applications
>>
>> If you don’t receive the mail with attachments within 2 hours of
>> receiving this notification mail, please let us know immediately.
>>
>> Copyright Compliance: Each article provided is procured only for the
>> use of the requestor. For reproduction / distribution, the law
>> requires ordering of multiple copies.
>>
>> Thanks & Regards
>>
>> Dipti Suvarna
>> QMed Services Pvt.Ltd
>> A-3, Shubham Centre, Cardinal Gracious Road,
>> Chakala, Andheri (E), Mumbai 400099, India.
>> Ph: 022-40054474 / 75
>> Email: articles@qmedin.com
>>
>> FROM: Clinigen Medical Information [mailto:mi@clinigengroup.com]
>> SENT: Wednesday, February 12, 2020 9:38 PM
>> TO: articles@qmedin.com
>> CC: Clinigen Medical Information
>> SUBJECT: Aldesleukin IL-2 Article request
>>
>> Dear Colleague,
>>
>> Could you kindly source below articles for us:
>>
>> * CAUSATIVE GENES FOR AMYOTROPHIC LATERAL SCLEROSIS. Maruyama H,
>> Morino H, Kawakami H. Brain Nerve. 2016 Sep;68(9):1081-1086
>>
>> * AMYOTROPHIC LATERAL SCLEROSIS. Kruger D. JAAPA. 2012
>> Jul;25(7):53-4
>>
>> * NEUROINFLAMMATORY MECHANISMS IN AMYOTROPHIC LATERAL SCLEROSIS
>> PATHOGENESIS. Thonhoff JR, Simpson EP, Appel SH. Curr Opin Neurol.
>> 2018 Oct;31(5):635-639.
>>
>> * INNATE IMMUNITY AND NEURODEGENERATION. Labzin LI, Heneka MT, Latz
>> E. Annu Rev Med. 2018 Jan 29;69:437-449
>>
>> * THE ECONOMIC IMPACT OF AMYOTROPHIC LATERAL SCLEROSIS: A SYSTEMATIC
>> REVIEW. Gladman M, Zinman L. Expert Rev Pharmacoecon Outcomes Res.
>> 2015 Jun;15(3):439-50
>>
>> * AMYOTROPHIC LATERAL SCLEROSIS: A HISTORICAL PERSPECTIVE. Katz JS,
>> Dimachkie MM, Barohn RJ. Neurol Clin. 2015 Nov;33(4):727-34
>>
>> * SIMPLE ANIMAL MODELS FOR AMYOTROPHIC LATERAL SCLEROSIS DRUG
>> DISCOVERY. Patten SA, Parker JA, Wen XY, Drapeau P. Expert Opin Drug
>> Discov. 2016 Aug;11(8):797-804. doi: 10.1080/17460441.2016.1196183.
>> Epub 2016 Jun 13. Review. PMID: 27249162
>>
>> * THE ROLE OF REGULATORY T LYMPHOCYTES IN AMYOTROPHIC LATERAL
>> SCLEROSIS. Beers DR, Zhao W, Appel SH. JAMA Neurol. 2018 Jun
>> 1;75(6):656-658. doi: 10.1001/jamaneurol.2018.0043.
>>
>> * RILUZOLE DOES NOT IMPROVE LIFESPAN OR MOTOR FUNCTION IN THREE ALS
>> MOUSE MODELS. Hogg MC, Halang L, Woods I, Coughlan KS, Prehn JHM.
>> Amyotroph Lateral Scler Frontotemporal Degener. 2018
>> Aug;19(5-6):438-445. doi: 10.1080/21678421.2017.1407796. Epub 2017 Dec
>> 8. PMID: 29221425
>>
>> * DEGENERATIVE AND ACQUIRED SPORADIC ADULT ONSET ATAXIA. Lieto M,
>> Roca A, Santorelli FM, Fico T, De Michele G, Bellofatto M, Saccà F,
>> De Michele G, Filla A. Neurol Sci. 2019 Jul;40(7):1335-1342. doi:
>> 10.1007/s10072-019-03856-w. Epub 2019 Mar 29. Review. PMID: 30927137
>>
>> * SHORT-TERM AND LOW-DOSE IL-2 THERAPY RESTORES THE TH17/TREG
>> BALANCE IN THE PERIPHERAL BLOOD OF PATIENTS WITH PRIMARY SJÖGREN’S
>> SYNDROME. Miao M, Hao Z, Guo Y, Zhang X, Zhang S, Luo J, Zhao X, Zhang
>> C, Liu X, Wu X, Xu D, Zhao J, Lu X, Gao C, Li X. Ann Rheum Dis. 2018
>> Dec;77(12):1838-1840. doi: 10.1136/annrheumdis-2018-213036. Epub 2018
>> Jun 23. No abstract available. PMID: 29936436
>>
>> * THE PROMISE OF LOW-DOSE INTERLEUKIN-2 THERAPY FOR AUTOIMMUNE AND
>> INFLAMMATORY DISEASES. Klatzmann D, Abbas AK. Nat Rev Immunol. 2015
>> May;15(5):283-94. doi: 10.1038/nri3823. Epub 2015 Apr 17. Review.
>> PMID: 25882245
>>
>> * BIOLOGY AND REGULATION OF IL-2: FROM MOLECULAR MECHANISMS TO HUMAN
>> THERAPY. Spolski R, Li P, Leonard WJ. Nat Rev Immunol. 2018
>> Oct;18(10):648-659. doi: 10.1038/s41577-018-0046-y. Review. PMID:
>> 30089912
>> * NEW INSIGHTS ON THE DISEASE CONTRIBUTION OF NEUROINFLAMMATION IN
>> AMYOTROPHIC LATERAL SCLEROSIS. Chiot A, Lobsiger CS, Boillée S. Curr
>> Opin Neurol. 2019 Oct;32(5):764-770. doi:
>> 10.1097/WCO.0000000000000729. PMID: 31306211
>>
>> * THE PROMISE OF LOW-DOSE INTERLEUKIN-2 THERAPY FOR AUTOIMMUNE AND
>> INFLAMMATORY DISEASES. Klatzmann D, Abbas AK. Nat Rev Immunol. 2015
>> May;15(5):283-94. doi: 10.1038/nri3823. Epub 2015 Apr 17. Review.
>> PMID: 25882245
>>
>> * LOW-DOSE INTERLEUKIN 2 IN PATIENTS WITH TYPE 1 DIABETES: A PHASE
>> 1/2 RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL. Hartemann A,
>> Bensimon G, Payan CA, Jacqueminet S, Bourron O, Nicolas N, Fonfrede M,
>> Rosenzwajg M, Bernard C, Klatzmann D. Lancet Diabetes Endocrinol. 2013
>> Dec;1(4):295-305. doi: 10.1016/S2213-8587(13)70113-X. Epub 2013 Oct 8.
>> PMID: 24622415
>>
>> * LOW-DOSE RECOMBINANT INTERLEUKIN-2 THERAPY: RATIONALE AND
>> POTENTIAL CLINICAL APPLICATIONS. Caligiuri MA. Semin Oncol. 1993
>> Dec;20(6 Suppl 9):3-10. Review. PMID: 8284689
>>
>> * THE ROLE OF REGULATORY T CELLS IN GRAFT-VERSUS-HOST DISEASE
>> MANAGEMENT. Whangbo JS, Antin JH, Koreth J. Expert Rev Hematol. 2020
>> Jan 11:1-14. doi: 10.1080/17474086.2020.1709436. [Epub ahead of print]
>> PMID: 31874061
>>
>> * COMPROMISED MAPK SIGNALING IN HUMAN DISEASES: AN UPDATE. Kim EK,
>> Choi EJ. Arch Toxicol. 2015 Jun;89(6):867-82. doi:
>> 10.1007/s00204-015-1472-2. Epub 2015 Feb 18. Review. PMID: 25690731
>>
>> Kind regards,
>>
>> Rahul
>>
>> CLINIGEN MEDICAL INFORMATION
>>
>> CLINIGEN GROUP
>>
>> t. +44 1932 824026
>> f. +44 1932 824226
>> e. mi@clinigengroup.com
>> w. www.clinigengroup.com [1]
>>
>> [2]
>>
>> [3]
>>
>> [4]
>>
>> This email (including any attachments) is confidential to the intended
>> addressee and may be subject to copyright. If you are not the intended
>> addressee, please do not read, print, re-transmit, copy, store, alter
>> or otherwise disclose it or any of its attachments to anyone; nor
>> should you act in reliance on it or any of its attachments. Instead,
>> please notify the error to the sender by email and immediately
>> permanently delete this email and any of its attachments from your
>> system.
>> Emails sent to and from Clinigen Group plc and/or its subsidiaries may
>> be monitored and read for legitimate business purposes, notably to
>> ensure compliance with the law and our regulatory obligations. Emails
>> and their attachments cannot be guaranteed to be secure or error-free,
>> and you should protect your systems. Clinigen Group plc and its
>> subsidiaries do not accept any liability arising from interception,
>> corruption, loss or destruction of this email (including any
>> attachment) or if it arrives late or incomplete or with viruses.
>> Clinigen Group plc is a public limited company (registered in England
>> and Wales No.06771928) whose registered office is at Pitcairn House,
>> Crown Square, Centrum 100, Burton-on-Trent, Staffordshire, DE14 2WW.
>> Subsidiary trading companies are as follows: Clinigen Healthcare
>> Limited (registered in England and Wales No.06252720); Clinigen CTS
>> Limited (registered in England and Wales No. 05016103), both with the
>> same registered office as Clinigen Group plc; and Idis Limited
>> (registered in England and Wales No.02143039) whose registered office
>> is at Idis House, Churchfield Road, Weybridge, Surrey KT13 8DB.
>> Clinigen Specialty Pharmaceuticals (SP), Clinigen Clinical Trial
>> Services (CTS), Idis Managed Access (MA) and Idis Global Access (GA)
>> are all trading names of Clinigen Group plc and/or its subsidiaries.
>> For further information please consult our website
>> www.clinigengroup.com. [6]
>>
>>
>>
>> Links:
>> ——
>> [1] https://www.clinigengroup.com
>> [2]
>> https://www.linkedin.com/company/clinigen-group?trk=biz-companies-cym
>> [3] https://twitter.com/clinigen?lang=en
>> [4] https://vimeo.com/clinigen
>> [5] http://www.loveyourpharmacist.com
>> [6] http://www.clinigengroup.com

Leave a Reply

Your email address will not be published.


Deprecated: Directive 'allow_url_include' is deprecated in Unknown on line 0